Jin Runming
Overview
Explore the profile of Jin Runming including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
10
Followers
0
Related Specialty
Related Specialty
Co-Authors
Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mengxuan S, Fen Z, Runming J
Front Pediatr
. 2022 Jul;
10:923419.
PMID: 35813376
With the markedly increased cure rate for children with newly diagnosed pediatric B-cell acute lymphoblastic leukemia (B-ALL), relapse and refractory B-ALL (R/R B-ALL) remain the primary cause of death worldwide...
2.
Xin N, Chunyan C, You Z, Lu P, Runming J, Fen Z
Front Pharmacol
. 2022 May;
13:769751.
PMID: 35517799
Anthracycline is a first-line chemotherapy drug used to treat childhood acute leukemia, which may cause cardiac toxicity including common arrhythmia, valve disease, pericardial effusion, and even rare cardiomyopathy and cardiac...
3.
Xin N, Fen Z, Li C, Yan X, Runming J
Front Pharmacol
. 2019 Oct;
10:1072.
PMID: 31607921
An 11-year-old male patient with the deletion of (Ikaros family zinc finger 1) and positive Breakpoint Cluster Region-C-Abelson oncogene 1() acute lymphoblastic leukemia developed mucositis, gastrointestinal toxicity, hepatotoxicity, myelosuppression, and...